Department of Pathology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
Infect Immun. 2011 Aug;79(8):3309-16. doi: 10.1128/IAI.05114-11. Epub 2011 May 16.
Klebsiella pneumoniae is a pathogen of increasing concern because of multidrug resistance, especially due to K. pneumoniae carbapenemases (KPCs). K. pneumoniae must acquire iron to replicate, and it utilizes iron-scavenging siderophores, such as enterobactin (Ent). The innate immune protein lipocalin 2 (Lcn2) is able to specifically bind Ent and disrupt iron acquisition. To determine whether K. pneumoniae must produce Lcn2-resistant siderophores to cause disease, we examined siderophore production by clinical isolates (n = 129) from respiratory, urine, blood, and stool samples and by defined siderophore mutants through genotyping and liquid chromatography-mass spectrometry. Three categories of K. pneumoniae isolates were identified: enterobactin positive (Ent(+)) (81%), enterobactin and yersiniabactin positive (Ent(+) Ybt(+)) (17%), and enterobactin and salmochelin (glycosylated Ent) positive (Ent(+) gly-Ent(+)) with or without Ybt (2%). Ent(+) Ybt(+) strains were significantly overrepresented among respiratory tract isolates (P = 0.0068) and β-lactam-resistant isolates (P = 0.0019), including the epidemic KPC-producing clone multilocus sequence type 258 (ST258). In ex vivo growth assays, gly-Ent but not Ybt allowed evasion of Lcn2 in human serum, whereas siderophores were dispensable for growth in human urine. In a murine pneumonia model, an Ent(+) strain was an opportunistic pathogen that was completely inhibited by Lcn2 but caused severe, disseminated disease in Lcn2(-/-) mice. In contrast, an Ent(+) Ybt(+) strain was a frank respiratory pathogen, causing pneumonia despite Lcn2. However, Lcn2 retained partial protection against disseminated disease. In summary, Ybt is a virulence factor that is prevalent among KPC-producing K. pneumoniae isolates and promotes respiratory tract infections through evasion of Lcn2.
肺炎克雷伯菌由于其多重耐药性,尤其是由于产碳青霉烯酶肺炎克雷伯菌(KPCs),其病原体地位日益受到关注。肺炎克雷伯菌必须获取铁才能进行复制,它利用铁螯合的铁载体,如肠杆菌素(Ent)。先天免疫蛋白脂联素 2(Lcn2)能够特异性结合 Ent 并破坏铁的获取。为了确定肺炎克雷伯菌是否必须产生耐 Lcn2 的铁载体来引起疾病,我们通过基因分型和液相色谱-质谱法检测了来自呼吸道、尿液、血液和粪便样本的临床分离株(n = 129)和确定的铁载体突变株的铁载体产生情况。鉴定出三类肺炎克雷伯菌分离株:肠杆菌素阳性(Ent(+))(81%)、肠杆菌素和耶尔森菌素阳性(Ent(+) Ybt(+))(17%)和肠杆菌素和沙门菌素(糖基化 Ent)阳性(Ent(+) gly-Ent(+)),无论是否存在 Ybt(2%)。呼吸道分离株(P = 0.0068)和β-内酰胺耐药分离株(P = 0.0019)中,Ent(+) Ybt(+) 菌株的比例明显更高,包括流行的产 KPC 克隆多位点序列型 258(ST258)。在体外生长试验中,糖基化 Ent 而不是 Ybt 允许在人血清中逃避 Lcn2,而铁载体对于在人尿液中的生长是可有可无的。在小鼠肺炎模型中,Ent(+) 菌株是一种机会性病原体,被 Lcn2 完全抑制,但在 Lcn2(-/-)小鼠中引起严重的、播散性疾病。相比之下,Ent(+) Ybt(+) 菌株是一种明显的呼吸道病原体,尽管存在 Lcn2 仍能引起肺炎。然而,Lcn2 对播散性疾病仍保留部分保护作用。总之,Ybt 是一种毒力因子,在产 KPC 的肺炎克雷伯菌分离株中很普遍,通过逃避 Lcn2 促进呼吸道感染。